Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 04, 2015 7:52 AM ET

Biotechnology

Company Overview of AVEO Pharmaceuticals, Inc.

Executive Profile

Peter Courossi MBA

Former Interim Chief Financial Officer, AVEO Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.

See Board Relationships
----

Background

Mr. Peter Courossi, MBA served as Chief Financial Officer of Civitas Therapeutics, Inc. Mr. Courossi served as Chief Financial Officer of Visterra, Inc. since September 2010. He served as Chief Financial Officer of Acceleron Pharma, Inc. since October 2006. Mr. Courossi served as Chief Financial Officer of Alinea Pharmaceuticals, Inc. Mr. Courossi served as Interim Chief Financial Officer of Sention, Inc. and AVEO Pharmaceuticals, Inc. He is a financial executive with ...

Corporate Headquarters

650 East Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-299-5000
Fax: --

Board Members Memberships

Director

Education

MBA
Babson College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
$230.0M
Amr Mamdouh Abdel Majid Chairman of the Board and Managing Director
GlaxoSmithKline S.A.E
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEO Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.